Solid Organ Transplants in HIV-Infected Patients

被引：0
作者：
Jack Harbell
Norah A. Terrault
Peter Stock
机构：
[1] University of California San Francisco,Department of Surgery
[2] University of California San Francisco,Department of Medicine
[3] University of California San Francisco,Division of Gastroenterology
[4] University of California San Francisco,Department of Surgery
来源：
Current HIV/AIDS Reports | 2013年 / 10卷
关键词：
Liver transplantation; Kidney transplantation; HIV; AIDS; Liver failure; Renal failure; Hepatitis B; Hepatitis C; Immune suppression; Opportunistic infection; Graft survival; Patient survival; Selection criteria; Antiretroviral therapy; CD4+ T-cell count;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
There is a growing need for kidney and liver transplants in persons living with HIV. Fortunately, with the significant advances in antiretroviral therapy and management of opportunistic infections, HIV infection is no longer an absolute contraindication for solid organ transplantation. Data from several large prospective multi-center cohort studies have shown that solid organ transplantation in carefully selected HIV-infected individuals is safe. However, significant challenges have been identified including prevention of acute rejection, management of drug-drug interactions and treatment of recurrent viral hepatitis. This article reviews the selection criteria, outcomes, and special management considerations for HIV-infected patients undergoing liver or kidney transplantation.
引用
收藏
页码：217 / 225
页数：8
相关论文
共 192 条
[51]  
Swanson SJ(2012)Preliminary study of two antiviral agents for hepatitis C genotype 1 N Engl J Med 366 216-44
[52]  
Agodoa LY(2011)An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases Hepatology 54 1433-23
[53]  
Kimmel PL(2013)A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1 J Hepatol 59 18-53
[54]  
Kumar MS(2013)Exploratory study of oral combination antiviral therapy for hepatitis C N Engl J Med 368 45-8
[55]  
Sierka DR(2003)Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy Am J Transplant 3 74-9
[56]  
Damask AM(1998)Spectrum of AIDS-associated malignant disorders Lancet 351 1833-45
[57]  
Qiu J(2001)Association of cancer with AIDS-related immunosuppression in adults Jama 285 1736-32
[58]  
Terasaki PI(2005)Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy J Natl Cancer Inst 97 425-94
[59]  
Waki K(2008)Cancer risk in people infected with human immunodeficiency virus in the United States Int J Cancer 123 187-63
[60]  
Carter JT(2008)Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era World J Gastroenterol 14 1657-67
12345678910